In this episode of the Oncology Insights Podcast, host Petros Grivas, MD, PhD, FASCO, is joined by Stanley Riddell, MD, a world leader in the field of cancer immunotherapy and professor emeritus of Fred Hutch’s Translational Science and Therapeutics Division. Over the course of a career spanning four decades at Fred Hutch, Riddell has helped shape the field’s progress — from early efforts addressing immune complications of bone marrow transplantation to pioneering genetically engineered T-cell therapies now transforming cancer treatment.
Main Topics:
Riddell’s career path and contributions to immunotherapy
Development and clinical success of CAR T-cell therapy
Challenges of translating immunotherapy from the lab to the clinic
Future of cancer treatment and possibilities for solid tumors
Collaboration between academia, industry and global health equity
The importance of perseverance and impactful research
YouTube | Spotify | Apple Podcasts | Libsyn | Amazon Music
- Episode 11: Inside the science changing lung cancer treatment with Dr. Lei Deng
- Episode 10: Inside the world of immunotherapy: innovations and access strategies with Dr. Mazyar Shadman
- Episode 9: Making more lung tumors immunotherapy‑sensitive with Dr. Christina Baik
- Episode 8: Dr. Rosa Nadal Rios’ journey in oncology
- Episode 7: Dr. Tom Lynch on leadership, innovation and cancer research
- Episode 6: Innovations in breast cancer care with Dr. Heather Parsons
- Episode 5: Dr. David Zhen on the future of gastrointestinal cancer treatment
- Episode 4: The future of breast cancer treatments with Dr. Vidhya Nair
- Episode 3: Dr. Rachael Safyan, a researcher focused on pancreatic, colorectal cancer
- Episode 2: Dr. Cristina Rodriguez on her journey in oncology, particularly in head and neck cancer
- Episode 1: Oncology Insights - A new podcast with Dr. Petros Grivas
